LMN.V vs. SMMT

Last updated Jun 9, 2026

LMN.V (Lumine Group Inc) and SMMT (Summit Therapeutics Inc.) are both stocks. LMN.V operates in Software - Application (Technology), while SMMT operates in Biotechnology (Healthcare). Over the past 3 years, LMN.V returned 5.50%/yr vs 103.39%/yr for SMMT. At a 0.07 correlation, their price movements are largely independent.

Performance

LMN.V vs. SMMT - Performance Comparison

The chart below illustrates the hypothetical performance of a CA$10,000 investment in Lumine Group Inc (LMN.V) and Summit Therapeutics Inc. (SMMT). The values are adjusted to include any dividend payments, if applicable.

Different Trading Currencies

LMN.V is traded in CAD, while SMMT is traded in USD. To make them comparable, the SMMT values have been converted to CAD using the latest available exchange rates.

Returns By Period

In the year-to-date period, LMN.V achieves a -16.54% return, which is significantly higher than SMMT's -17.85% return.

LMN.V

• 1D: -3.21%
• 1M: 11.96%
• YTD: -16.54%
• 6M: -20.50%
• 1Y: -50.93%
• 3Y*: 5.50%
• 5Y*: —
• 10Y*: —

SMMT

• 1D: -4.20%
• 1M: -20.34%
• YTD: -17.85%
• 6M: -23.64%
• 1Y: -30.08%
• 3Y*: 103.39%
• 5Y*: 17.09%
• 10Y*: 5.10%

*Multi-year figures are annualized to reflect compound growth (CAGR)

LMN.V vs. SMMT - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023
LMN.V Lumine Group Inc	-16.54%	-34.03%	37.59%	84.00%
SMMT Summit Therapeutics Inc.	-17.85%	-6.46%	641.61%	48.08%

Correlation

The correlation between LMN.V and SMMT is 0.05, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.05
Correlation (3Y) Calculated over the trailing 3-year period	0.07
Correlation (All Time) Calculated using the full available price history since Mar 24, 2023	0.07

Fundamentals

Market Cap LMN.V : CA$5.81B SMMT : $10.94B
EPS LMN.V : CA$0.48 SMMT : -$1.60
PB Ratio LMN.V : 7.00 SMMT : 20.04
Total Revenue (TTM) LMN.V : CA$792.89M SMMT : $0.00
Gross Profit (TTM) LMN.V : CA$271.95M SMMT : -$83.36K
EBITDA (TTM) LMN.V : CA$253.96M SMMT : -$738.34M

Return for Risk

LMN.V vs. SMMT — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

LMN.V

LMN.V Risk / Return Rank: 10
LMN.V Sharpe Ratio Rank: 6
LMN.V Sortino Ratio Rank: 5
LMN.V Omega Ratio Rank: 7
LMN.V Calmar Ratio Rank: 13
LMN.V Martin Ratio Rank: 18

SMMT

SMMT Risk / Return Rank: 25
SMMT Sharpe Ratio Rank: 24
SMMT Sortino Ratio Rank: 28
SMMT Omega Ratio Rank: 28
SMMT Calmar Ratio Rank: 21
SMMT Martin Ratio Rank: 24

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

LMN.V vs. SMMT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Lumine Group Inc (LMN.V) and Summit Therapeutics Inc. (SMMT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	LMN.V	SMMT	Difference
Sharpe ratio: Return per unit of total volatility	-0.96	-0.40	-0.56
Sortino ratio: Return per unit of downside risk	-1.65	-0.11	-1.54
Omega ratio: Gain probability vs. loss probability	0.82	0.99	-0.16
Calmar ratio: Return relative to maximum drawdown	-0.77	-0.57	-0.20
Martin ratio: Return relative to average drawdown	-1.13	-0.88	-0.25
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

LMN.V vs. SMMT - Sharpe Ratio Comparison

The current LMN.V Sharpe Ratio is -0.96, which is lower than the SMMT Sharpe Ratio of -0.40. The chart below compares the historical Sharpe Ratios of LMN.V and SMMT, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	LMN.V	SMMT	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.96	-0.40	-0.56
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	0.09	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	0.04	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.22	0.03	+0.19

Drawdowns

LMN.V vs. SMMT - Drawdown Comparison

The maximum LMN.V drawdown since its inception was -66.64%, smaller than the maximum SMMT drawdown of -95.31%. Use the drawdown chart below to compare losses from any high point for LMN.V and SMMT.

Drawdown Indicators

	LMN.V	SMMT	Difference
Max Drawdown Largest peak-to-trough decline	-66.64%	-95.31%	+28.67%
Max Drawdown (1Y) Largest decline over 1 year	-66.64%	-53.14%	-13.50%
Max Drawdown (3Y) Largest decline over 3 years	-66.64%	-62.82%	-3.82%
Max Drawdown (5Y) Largest decline over 5 years	—	-91.30%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-95.31%	—
Current Drawdown Current decline from peak	-58.26%	-61.36%	+3.10%
Average Drawdown Average peak-to-trough decline	-17.68%	-56.13%	+38.45%
Ulcer Index Depth and duration of drawdowns from previous peaks	45.06%	34.21%	+10.85%

Volatility

LMN.V vs. SMMT - Volatility Comparison

The current volatility for Lumine Group Inc (LMN.V) is 14.32%, while Summit Therapeutics Inc. (SMMT) has a volatility of 22.31%. This indicates that LMN.V experiences smaller price fluctuations and is considered to be less risky than SMMT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	LMN.V	SMMT	Difference
Volatility (1M) Calculated over the trailing 1-month period	14.32%	22.31%	-7.99%
Volatility (6M) Calculated over the trailing 6-month period	38.82%	56.67%	-17.85%
Volatility (1Y) Calculated over the trailing 1-year period	53.25%	76.06%	-22.81%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	45.05%	186.48%	-141.43%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	45.05%	145.53%	-100.48%

Dividends

LMN.V vs. SMMT - Dividend Comparison

Neither LMN.V nor SMMT has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both LMN.V and SMMT in my portfolio?

LMN.V and SMMT have a correlation of 0.05, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.